# A Phase 3 Study to Evaluate the Efficacy and Safety of JointStem in Treatment of Osteoarthritis

> **NCT03990805** · PHASE3 · COMPLETED · sponsor: **R-Bio** · enrollment: 260 (actual)

## Conditions studied

- Degenerative Arthritis
- Knee Osteoarthritis

## Interventions

- **BIOLOGICAL:** JOINTSTEM
- **DRUG:** saline

## Key facts

- **NCT ID:** NCT03990805
- **Lead sponsor:** R-Bio
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-11
- **Primary completion:** 2020-12-15
- **Final completion:** 2020-12-15
- **Target enrollment:** 260 (ACTUAL)
- **Last updated:** 2022-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03990805

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03990805, "A Phase 3 Study to Evaluate the Efficacy and Safety of JointStem in Treatment of Osteoarthritis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03990805. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*